Document is current

Article History

Received: 28 February 2025

Accepted: 24 March 2025

First Online: 14 April 2025

Declarations

:

: EG received honoraria for lectures from Roche Diagnostics, AstraZeneca, Bayer, Daiichi-Sankyo, and Lilly Eli Deutschland. He serves as a consultant for Roche Diagnostics, BRAHMS Thermo Fisher Scientific, Boehringer Ingelheim and has received research funding from BRAHMS Thermo Fisher Scientific, Roche Diagnostics, Bayer Vital, and Daiichi Sankyo. JTN and RT are listed as co-inventors of an international patent on the use of a computing device to estimate the probability of myocardial infarction (International Publication Number WO2022043229A1) as well as are co-founders and shareholders of the ART-EMIS Hamburg GmbH. JN reports research support from the German Foundation of Heart Research and the Werner Otto Foundation, and received speaker/consulting honoraria from Siemens Healthineers, Roche and PHC. MB received research support from AstraZeneca. MMH received research funding from BRAHMS Thermo Fisher Scientific and Roche Diagnostics and served as a consultant to ZOLL CMS GmbH. NF has received speaker honoraria from Daiichi Sankyo, Astra Zeneca, Boehringer Ingelheim, and Bayer Vital. RT holds a professorship in clinical cardiology at the University Medical Center Hamburg-Eppendorf, supported by the Kühne Foundation, and reports research support from the German Center for Cardiovascular Research (DZHK), the Swiss National Science Foundation (Grant No. P300PB_167803), the Swiss Heart Foundation, the Swiss Society of Cardiology, the Cardiovascular Research Foundation Basel, the University of Basel. and the University Hospital Basel and speaker honoraria/consulting honoraria from Abbott, Amgen, Astra Zeneca, Roche, Siemens, Singulex, and Thermo Scientific BRAHMS. SB received institutional grants from Abbott Diagnostics, Bayer, Siemens, Singulex, and Thermo Fisher, consulting fees from Bayer, Novartis, and Thermo Fisher, as well as speaker honoraria from Abbott, Astra Zeneca, Bayer, Amgen, Medtronic, Pfizer, Siemens, and Thermo Fisher. There are no disclosures for CR, CS, and MY.

: This study was performed in line with the principles of the1964 Declaration of Helsinki and its later amendments. Approval was granted by the Ethics Committee of the University of Heidelberg. For this retrospective study using data from clinical routine care, informed consent was waived by local ethical committee.